Teva Pharmaceutical Industries
TEVA
#713
Rank
S$42.31 B
Marketcap
S$36.88
Share price
0.18%
Change (1 day)
54.62%
Change (1 year)

Teva Pharmaceutical Industries (TEVA) - Cash on Hand

Cash on Hand as of September 2025 : S$2.85 Billion

According to Teva Pharmaceutical Industries's latest financial reports the company has S$2.85 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Teva Pharmaceutical Industries - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31S$4.48 B5.28%
2023-12-31S$4.26 B13.46%
2022-12-31S$3.75 B28.29%
2021-12-31S$2.92 B1.63%
2020-12-31S$2.88 B8.16%
2019-12-31S$2.66 B9.37%
2018-12-31S$2.43 B89.01%
2017-12-31S$1.28 B-9.92%
2016-12-31S$1.42 B-85.45%
2015-12-31S$9.82 B234.05%
2014-12-31S$2.94 B123.65%
2013-12-31S$1.31 B-62.65%
2012-12-31S$3.52 B148.05%
2011-12-31S$1.41 B-14.18%
2010-12-31S$1.65 B-47.59%
2009-12-31S$3.15 B15.72%
2008-12-31S$2.72 B-34.08%
2007-12-31S$4.13 B32%
2006-12-31S$3.13 B-14.9%
2005-12-31S$3.68 B116.86%
2004-12-31S$1.69 B-27.54%
2003-12-31S$2.34 B29.18%
2002-12-31S$1.81 B24.03%
2001-12-31S$1.46 B98.8%
2000-12-31S$0.73 B368.11%
1999-12-31S$0.15 B93.5%
1998-12-31S$81.22 M-17.78%
1997-12-31S$98.79 M2.02%
1996-12-31S$96.84 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Novartis
NVS
S$12.63 B 342.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
S$13.54 B 374.44%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
S$5.75 B 101.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
S$19.41 B 580.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$23.60 B 726.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
S$1.01 B-64.33%๐Ÿ‡ฎ๐Ÿ‡ณ India
AstraZeneca
AZN
S$10.60 B 271.40%๐Ÿ‡ฌ๐Ÿ‡ง UK